To date, 17 of 19 subjects have had their six-month follow-up visit, during which time subjects had their overall health evaluated. This included subjective and objective assessment of verum and placebo injected sites and digital images were taken of the scalp and injection areas. The digital images will be used to assess any treatment response and any post-injection changes in scalp health compared to baseline and between the two treatment areas. The remaining two patients are scheduled to complete their follow-up visits before the end of March. Four patients will complete 12-month follow-up visits in that same time frame.
It seems like scientists have been talking about hair multiplication (aka "hair cloning") for decades. Hair loss patients and hair doctors are wondering, are they making any progress? RepliCel, located in Vancouver, Canada is one of the few companies performing this state of the art research and there are 19 participants in this part of the hair cloning trial. No detailed information has been released by Replicel regarding their observations at the treatment areas so far.
At Bauman Medical Group, we have many patients who might be good candidates for hair multiplication/hair cloning procedures if the technology turns out to be viable! For now, however, we will surely have to stay tuned! --Dr. Alan Bauman